Cardiac Rhythm Management Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Cardiac Rhythm Management Devices Pipeline Market Report Overview

Cardiac Rhythm Management (CRM) devices are those devices which are used to restore the natural synchronized pumping rhythm of the heart. These include Pacemakers, Cardiac Resynchronisation Therapy (CRT), Implantable Loop Recorders and Implantable Cardioverter Defibrillators (ICD). These devices are used for the treatment of congestive heart failure.

The Cardiac Rhythm Management Devices pipeline market research report provides comprehensive information about the Cardiac Rhythm Management Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiac Rhythm Management Devices Pipeline Market Segments

Some of the segments in the Cardiac Rhythm Management Devices pipeline market are Pacemakers, Cardiovascular Pacing and ICD Leads, Implantable Cardioverter Defibrillators (ICD), Cardiac Resynchronisation Therapy – Defibrillators (CRT-D), Cardiac Resynchronisation Therapy (CRT), Dual Chamber Pacemakers, Implantable Loop Recorders (ILR), Cardiac Resynchronisation Therapy – Pacemakers (CRT-P), Single Chamber Pacemakers, and Single Chamber Pacemakers with Leads. As of April 2023, Pacemakers has the highest number of pipeline products.

Pacemaker: A pacemaker is a device designed to regulate the beating of the heart by providing electrical impulses delivered by the electrodes contacting the heart muscle. It can be a single chamber or dual chamber type.

Implantable Loop Recorders (ILR): An Implantable loop recorder (ILR) is a subcutaneous, single-lead, electrocardiographic (ECG) monitoring device which is used for diagnosis in patients with recurrent unexplained episodes of palpitations or syncope. It is also useful for long-term monitoring in patients at risk for or with atrial fibrillation, structural heart disease, bundle branch block, recurrent neurally mediated syncope etc. The device consists of an insertable recorder that comes with a battery and two surface electrodes.

Cardiac Rhythm Management Devices Pipeline Market Analysis, by Segments, 2023 (%)

Cardiac Rhythm Management Devices Pipeline Market Analysis, by Segments, 2023 (%)

For more segment insights into the Cardiac Rhythm Management Devices pipeline market, download a free report sample

Cardiac Rhythm Management Devices Pipeline Market Segmentation by Territories

Some of the territories in the Cardiac Rhythm Management Devices pipeline market are the US, Europe, China, Japan, Israel, Australia, India, New Zealand, South Korea, and Taiwan. As of April 2023, the US has the highest number of pipeline products.

Cardiac Rhythm Management Devices Pipeline Market Analysis, by Territories, 2023 (%)

Cardiac Rhythm Management Devices Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the Cardiac Rhythm Management Devices pipeline market, download a free report sample

Cardiac Rhythm Management Devices Pipeline Market Segmentation by Regulatory Paths

Some of the regulatory paths in the Cardiac Rhythm Management Devices pipeline market are PMA, CE, NMPA, Shonin, TGA, Ninsho, 510(k), ICAC, MDL, and NIFDS. As of April 2023, PMA is the most followed pathway for pipeline products.

Cardiac Rhythm Management Devices Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Cardiac Rhythm Management Devices Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the Cardiac Rhythm Management Devices pipeline market, download a free report sample

Cardiac Rhythm Management Devices Pipeline Market – Competitive Landscape

Some of the key companies in the Cardiac Rhythm Management Devices pipeline market are A3 Remote Monitoring Technologies Pvt Ltd, Advanced BioInformatics GmbH, AIS Inc., APT Medical Inc, Arizona State University, Arrhythmia Dynamics LLC, AtaCor Medical Inc, Bionet Sonar Inc, Biotronik SE & Co KG, and Boston Scientific Corp.

Arizona State University: Headquartered in Tempe, Arizona, the US, Arizona State University (ASU) is an educational and research university that provides entrepreneurship solutions. The university’s services include academic services, institutes and initiative consulting, industry engagement, knowledge enterprise development, support and consulting, global development, entrepreneurship, technology transfer, and undergraduate opportunity services. Its academic services comprise of degree programs, college and school programs, academic calendars, libraries, online degree, registration and scholarships, and financial aid services.

Cardiac Rhythm Management Devices Pipeline Market Report Overview

Key Territories The US, Europe, China, Japan, Israel, Australia, India, New Zealand, South Korea, and Taiwan
Key Segments Pacemakers, Cardiovascular Pacing and ICD Leads, Implantable Cardioverter Defibrillators (ICD), Cardiac Resynchronisation Therapy – Defibrillators (CRT-D), Cardiac Resynchronisation Therapy (CRT), Dual Chamber Pacemakers, Implantable Loop Recorders (ILR), Cardiac Resynchronisation Therapy – Pacemakers (CRT-P), Single Chamber Pacemakers, and Single Chamber Pacemakers with Leads
Key Regulatory Paths PMA, CE, NMPA, Shonin, TGA, Ninsho, 510(k), ICAC, MDL, and NIFDS
Leading Companies A3 Remote Monitoring Technologies Pvt Ltd, Advanced BioInformatics GmbH, AIS Inc., APT Medical Inc, Arizona State University, Arrhythmia Dynamics LLC, AtaCor Medical Inc, Bionet Sonar Inc, Biotronik SE & Co KG, and Boston Scientific Corp

Segments Covered in the Report

Cardiac Rhythm Management Devices Pipeline Market Segments Outlook

  • Pacemakers
  • Cardiovascular Pacing and ICD Leads
  • Implantable Cardioverter Defibrillators (ICD)
  • Cardiac Resynchronisation Therapy – Defibrillators (CRT-D)
  • Cardiac Resynchronisation Therapy (CRT)
  • Dual Chamber Pacemakers
  • Implantable Loop Recorders (ILR)
  • Cardiac Resynchronisation Therapy – Pacemakers (CRT-P)
  • Single Chamber Pacemakers
  • Single Chamber Pacemakers with Leads
  • Subcutaneous Implantable Cardioverter Defibrillators (ICD)
  • Single Chamber Implantable Cardioverter Defibrillators (ICD)
  • Dual Chamber Leadless Pacemakers
  • Single Chamber Leadless Pacemakers
  • Cardiac Rhythm Management Devices Pipeline Market Territories Outlook
  • Cardiac Rhythm Management Devices Pipeline Market Regulatory Paths Outlook

Cardiac Rhythm Management Devices Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Japan
  • Israel
  • Australia
  • India
  • New Zealand
  • South Korea
  • Taiwan
  • United Kingdom
  • Canada
  • Bangladesh
  • Costa Rica
  • El Salvador
  • Singapore
  • Mexico

Cardiac Rhythm Management Devices Pipeline Market Regulatory Paths Outlook

  • PMA
  • CE
  • NMPA
  • Shonin
  • TGA
  • Ninsho
  • 510(k)
  • ICAC
  • MDL
  • NIFDS
  • BOPA
  • HDE Approvals
  • UKCA
  • HSA

Scope

  • Extensive coverage of the Cardiac Rhythm Management Devices under development
  • Reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • Reviews the major players involved in the development of Cardiac Rhythm Management Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Rhythm Management Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

A3 Remote Monitoring Technologies Pvt Ltd
Advanced BioInformatics GmbH
AIS Inc.
APT Medical Inc
Arizona State University
Arrhythmia Dynamics LLC
AtaCor Medical Inc
Bionet Sonar Inc
Biotronik SE & Co KG
Boston Scientific Corp
Boston TransTec LLC
Cairdac
CardiaLen, Inc.
Cardioalarm, Inc
Ceryx Medical Ltd
Children’s National Health System
City Labs Inc
Corhythm Inc
Coridea, LLC
CVRx Inc
DHS Medical
Drexel University
Duke University
EBR Systems Inc
Endomimetics LLC
Endurance Rhythm Inc.
Hadassah Medical Center
Impulse Dynamics Germany GmbH
InnerPulse Inc (Inactive)
Integer Holdings Corp
IRadimed Corp
Johns Hopkins University
Kenergy Inc.
Krisara Engineering, LLC
Massachusetts General Hospital
Max Planck Institute for Dynamics and Self-Organization
Mayo Clinic
Medicool Technologies Inc
Medtronic Inc
Medtronic Plc
MicroPort CRM SA
MicroPort Scientific Corp
NanoLinea
NewPace Ltd
Northwestern University
NuVascular Technologies Inc
Odem Medical Ltd
Ohio State University
Osypka Medical GmbH
Perpetuum Ltd
Queen Mary University of London
Rice University
Shaanxi Qinming Medical Instruments Co Ltd
Smartwave Medical Ltd (Inactive)
Spectranetics Corp
St. Jude Medical LLC
SUNY Downstate Medical Center
Suzhou Singular Medical Co Ltd
Teleflex Inc
Thayer School of Engineering at Dartmouth
U.S. Stem Cell Inc
University of Arizona
University of Bern
University of California Los Angeles
University of Chicago
University of Glasgow
University of Michigan
University of Southern California
University of Utah

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 8

|1.2 List of Figures 16

2 Introduction 17

2.1 Cardiac Rhythm Management Devices Overview 17

3 Products under Development 19

3.1 Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development 19

3.2 Cardiac Rhythm Management Devices – Pipeline Products by Segment 20

3.3 Cardiac Rhythm Management Devices – Pipeline Products by Territory 21

3.4 Cardiac Rhythm Management Devices – Pipeline Products by Regulatory Path 22

3.5 Cardiac Rhythm Management Devices – Pipeline Products by Estimated Approval Date 23

3.6 Cardiac Rhythm Management Devices – Ongoing Clinical Trials 24

4 Cardiac Rhythm Management Devices – Pipeline Products under Development by Companies 25

4.1 Cardiac Rhythm Management Devices Companies – Pipeline Products by Stage of Development 25

4.2 Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development 28

5 Cardiac Rhythm Management Devices Companies and Product Overview 32

5.1 A3 Remote Monitoring Technologies Pvt Ltd Company Overview 32

5.1.1 A3 Remote Monitoring Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.2 Advanced BioInformatics GmbH Company Overview 33

5.2.1 Advanced BioInformatics GmbH Pipeline Products & Ongoing Clinical Trials Overview 33

5.3 AIS Inc. Company Overview 34

5.3.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

5.4 APT Medical Inc Company Overview 35

5.4.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.5 Arizona State University Company Overview 36

5.5.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 36

5.6 Arrhythmia Dynamics LLC Company Overview 37

5.6.1 Arrhythmia Dynamics LLC Pipeline Products & Ongoing Clinical Trials Overview 37

5.7 AtaCor Medical Inc Company Overview 38

5.7.1 AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.8 Bionet Sonar Inc Company Overview 43

5.8.1 Bionet Sonar Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.9 Biotronik SE & Co KG Company Overview 44

5.9.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 44

5.10 Boston Scientific Corp Company Overview 49

5.10.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 49

5.11 Boston TransTec LLC Company Overview 62

5.11.1 Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 62

5.12 Cairdac Company Overview 63

5.12.1 Cairdac Pipeline Products & Ongoing Clinical Trials Overview 63

5.13 CardiaLen, Inc. Company Overview 64

5.13.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64

5.14 Cardioalarm, Inc Company Overview 67

5.14.1 Cardioalarm, Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.15 Ceryx Medical Ltd Company Overview 68

5.15.1 Ceryx Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 68

5.16 Children’s National Health System Company Overview 69

5.16.1 Children’s National Health System Pipeline Products & Ongoing Clinical Trials Overview 69

5.17 City Labs Inc Company Overview 70

5.17.1 City Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.18 Corhythm Inc Company Overview 71

5.18.1 Corhythm Inc Pipeline Products & Ongoing Clinical Trials Overview 71

5.19 Coridea, LLC Company Overview 72

5.19.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 72

5.20 CVRx Inc Company Overview 73

5.20.1 CVRx Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.21 DHS Medical Company Overview 76

5.21.1 DHS Medical Pipeline Products & Ongoing Clinical Trials Overview 76

5.22 Drexel University Company Overview 78

5.22.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 78

5.23 Duke University Company Overview 79

5.23.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 79

5.24 EBR Systems Inc Company Overview 80

5.24.1 EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 80

5.25 Endomimetics LLC Company Overview 84

5.25.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 84

5.26 Endurance Rhythm Inc. Company Overview 86

5.26.1 Endurance Rhythm Inc. Pipeline Products & Ongoing Clinical Trials Overview 86

5.27 Hadassah Medical Center Company Overview 87

5.27.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 87

5.28 Impulse Dynamics Germany GmbH Company Overview 88

5.28.1 Impulse Dynamics Germany GmbH Pipeline Products & Ongoing Clinical Trials Overview 88

5.29 InnerPulse Inc (Inactive) Company Overview 89

5.29.1 InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 89

5.30 Integer Holdings Corp Company Overview 91

5.30.1 Integer Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 91

5.31 IRadimed Corp Company Overview 92

5.31.1 IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview 92

5.32 Johns Hopkins University Company Overview 93

5.32.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 93

5.33 Kenergy Inc. Company Overview 96

5.33.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 96

5.34 Krisara Engineering, LLC Company Overview 98

5.34.1 Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview 98

5.35 Massachusetts General Hospital Company Overview 99

5.35.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 99

5.36 Max Planck Institute for Dynamics and Self-Organization Company Overview 101

5.36.1 Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview 101

5.37 Mayo Clinic Company Overview 102

5.37.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 102

5.38 Medicool Technologies Inc Company Overview 104

5.38.1 Medicool Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 104

5.39 Medtronic Inc Company Overview 105

5.39.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview 105

5.40 Medtronic Plc Company Overview 106

5.40.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 106

5.41 MicroPort CRM SA Company Overview 115

5.41.1 MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview 115

5.42 MicroPort Scientific Corp Company Overview 145

5.42.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 145

5.43 NanoLinea Company Overview 151

5.43.1 NanoLinea Pipeline Products & Ongoing Clinical Trials Overview 151

5.44 NewPace Ltd Company Overview 152

5.44.1 NewPace Ltd Pipeline Products & Ongoing Clinical Trials Overview 152

5.45 Northwestern University Company Overview 153

5.45.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 153

5.46 NuVascular Technologies Inc Company Overview 154

5.46.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 154

5.47 Odem Medical Ltd Company Overview 155

5.47.1 Odem Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 155

5.48 Ohio State University Company Overview 157

5.48.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 157

5.49 Osypka Medical GmbH Company Overview 158

5.49.1 Osypka Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 158

5.50 Perpetuum Ltd Company Overview 159

5.50.1 Perpetuum Ltd Pipeline Products & Ongoing Clinical Trials Overview 159

5.51 Queen Mary University of London Company Overview 160

5.51.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 160

5.52 Rice University Company Overview 161

5.52.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 161

5.53 Shaanxi Qinming Medical Instruments Co Ltd Company Overview 163

5.53.1 Shaanxi Qinming Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 163

5.54 Smartwave Medical Ltd (Inactive) Company Overview 164

5.54.1 Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 164

5.55 Spectranetics Corp Company Overview 165

5.55.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 165

5.56 St. Jude Medical LLC Company Overview 166

5.56.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 166

5.57 SUNY Downstate Medical Center Company Overview 170

5.57.1 SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 170

5.58 Suzhou Singular Medical Co Ltd Company Overview 171

5.58.1 Suzhou Singular Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 171

5.59 Teleflex Inc Company Overview 173

5.59.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 173

5.60 Thayer School of Engineering at Dartmouth Company Overview 174

5.60.1 Thayer School of Engineering at Dartmouth Pipeline Products & Ongoing Clinical Trials Overview 174

5.61 U.S. Stem Cell Inc Company Overview 175

5.61.1 U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 175

5.62 University of Arizona Company Overview 176

5.62.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 176

5.63 University of Bern Company Overview 177

5.63.1 University of Bern Pipeline Products & Ongoing Clinical Trials Overview 177

5.64 University of California Los Angeles Company Overview 178

5.64.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 178

5.65 University of Chicago Company Overview 180

5.65.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 180

5.66 University of Glasgow Company Overview 181

5.66.1 University of Glasgow Pipeline Products & Ongoing Clinical Trials Overview 181

5.67 University of Michigan Company Overview 182

5.67.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 182

5.68 University of Southern California Company Overview 183

5.68.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 183

5.69 University of Utah Company Overview 185

5.69.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 185

6 Cardiac Rhythm Management Devices- Recent Developments 186

6.1 Mar 30, 2023: Integer Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023 186

6.2 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 186

6.3 Mar 13, 2023: T2 Biosystems Announces Fourth Quarter and Full Year 2022 Financial Results 186

6.4 Feb 21, 2023: Orthofix Medical Schedules Fourth Quarter Earnings Release and Conference Call for March 6, 2023 188

6.5 Feb 16, 2023: Integer Holdings Reports Results for Fourth Quarter and Full Year 2022 188

6.6 Feb 09, 2023: iRhythm Technologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 190

6.7 Feb 08, 2023: Nihon Kohden Announces Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2023 191

6.8 Feb 07, 2023: JMS Co Announces Financial Results for the 3rd Quarter of FYE March 2023 191

6.9 Feb 06, 2023: Surmodics Lays off 58 employees 192

6.10 Feb 06, 2023: Surmodics Reports First Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance 192

6.11 Feb 01, 2023: Japan Lifeline Announces Consolidated Financial Results for the Nine months Ended December 31, 2022 194

6.12 Jan 31, 2023: Fukuda Denshi Announces Summary of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023 195

6.13 Jan 31, 2023: Surmodics to Host Virtual Annual Meeting of Shareholders 197

6.14 Jan 30, 2023: Medtronic appoints Michael Blackwell as India vice-president 197

6.15 Jan 30, 2023: Philips to lay off 6,000 employees in drive to improve profitability 197

6.16 Jan 23, 2023: T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results 197

6.17 Jan 12, 2023: CVRx to Report Fourth Quarter and Fiscal Year 2022 Financial and Operating Results and Host Conference Call on January 26, 2023 198

6.18 Jan 09, 2023: Orthofix Medical Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results 198

6.19 Jan 09, 2023: iRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare Conference 200

6.20 Jan 09, 2023: CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results 201

6.21 Jan 02, 2023: Ventripoint Diagnostics Announces Dr. Alvira Macanovic as President and CEO 202

6.22 Dec 20, 2022: CVRx Appoints Industry Veteran Kevin Hykes to Board of Directors 203

6.23 Nov 25, 2022: Concord Medical Schedules 2022 Annual Meeting of Shareholders 203

6.24 Nov 23, 2022: Medtronic Reports Quarterly Earnings 204

6.25 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 204

6.26 Nov 22, 2022: Mayo Clinic surgeon takes the wheel as Kwik Trip’s new CEO 210

6.27 Nov 17, 2022: Mindray North America unveils new true to life vital signs monitor 210

6.28 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 210

6.29 Nov 09, 2022: Nihon Kohden Consolidated Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2023 210

6.30 Nov 04, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended September 2022 211

6.31 Oct 31, 2022: Fukuda Denshi Financial Results for the Second Quarter of the Fiscal Year Ending March 2023 211

6.32 Oct 31, 2022: Fukuda Denshi Notice of the Revision Forecast of the Financial Results, Distribution of Surplus and Year-end Dividend Forecast, Stock Split 212

6.33 Oct 27, 2022: Integer Holdings Reports Third Quarter 2022 Results 213

6.34 Oct 25, 2022: Orthofix Medical Schedules Third Quarter Earnings Release and Conference Call for November 3, 2022 214

6.35 Oct 24, 2022: Philips To Cut 4000 Jobs As Company Faces Multiple Challenges 214

6.36 Oct 19, 2022: Nihon Kohden Announces a Revision to its Forecast for Financial Results 214

6.37 Oct 12, 2022: Philips provides update on its financial performance in Q3 2022 215

6.38 Oct 12, 2022: T2 Biosystems Announces Preliminary Third Quarter 2022 Financial Results and Updates 2022 Financial Outlook 216

6.39 Oct 11, 2022: Orthofix Announces Preliminary Third Quarter and Year-To-Date 2022 Net Sales Results 217

6.40 Sep 30, 2022: Natalie Caine named chief administrative officer at Mayo Clinic in Rochester 218

6.41 Sep 23, 2022: Concord Medical Reports Financial Results for the First Half of 2022 219

6.42 Sep 14, 2022: Orthofix Medical Announces Participation in Upcoming Sidoti Virtual Investor Conference 221

6.43 Sep 07, 2022: Medtronic to appear at September investor conferences 221

6.44 Aug 31, 2022: iRhythm Technologies to Host Analyst & Investor Day on September 21, 2022 221

6.45 Aug 23, 2022: Surmodics to Present at Upcoming Gilmartin Emerging Growth Company Showcase Wednesday, August 31, 2022 221

6.46 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 222

6.47 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 224

6.48 Aug 18, 2022: Philips to convene Extraordinary General Meeting of Shareholders to appoint Roy Jakobs as new President and Chief Executive Officer 227

6.49 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule 227

6.50 Aug 08, 2022: ClearPoint Neuro Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs 228

6.51 Aug 05, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended June 2022 228

6.52 Jul 29, 2022: CVRx to Present at the Canaccord Genuity 42nd Annual Growth Conference 229

6.53 Jul 28, 2022: Integer Holdings Reports Second Quarter 2022 Results 229

6.54 Jul 25, 2022: iRhythm Technologies Announces the Addition of Two Executive Leaders to Advance Strategic Growth and Operational Excellence 230

6.55 Jun 28, 2022: Japan Lifeline Co. Notice of Resolution of the 42nd Annual General Meeting of Shareholders 230

6.56 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 231

6.57 Jun 07, 2022: Ventripoint exhibiting at the American Society of Echocardiography 33rd Annual Scientific Session 232

6.58 May 31, 2022: CONMED Announces Private Offering of $600 Million of Convertible Senior Notes 232

6.59 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 234

6.60 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 234

6.61 May 16, 2022: Orthofix Medical Announces Participation in Upcoming UBS Global Healthcare Conference 234

6.62 May 13, 2022: Nihon Kohden Consolidated Financial Results for the Fiscal Year Ended March 31, 2022 235

6.63 May 13, 2022: Nihon Kohden announces FY2021 consolidated financial results 236

6.64 May 10, 2022: Stereotaxis Reports 2022 First Quarter Financial Results 236

6.65 May 09, 2022: BaroPace Adds Michael Coyle to Board 237

6.66 May 05, 2022: iRhythm Technologies Announces First Quarter 2022 Financial Results 238

6.67 May 04, 2022: Conmed Announces First Quarter 2022 Financial Results 239

6.68 Apr 29, 2022: Concord Medical Files 2021 Annual Report on Form 20-F 241

6.69 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022 241

6.70 Apr 28, 2022: Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 6, 2022 242

6.71 Apr 28, 2022: T2 Biosystems Announces Formation and Members of Scientific Advisory Board 242

6.72 Apr 28, 2022: Integer Holdings Corporation Reports First Quarter 2022 Results 244

6.73 Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022 246

6.74 Apr 25, 2022: CVRx Reports First Quarter 2022 Financial and Operating Results 249

7 Appendix 251

7.1 Methodology 251

7.2 About GlobalData 254

7.3 Contact Us 254

7.4 Disclaimer 254

Frequently asked questions

Cardiac Rhythm Management Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Cardiac Rhythm Management Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cardiac Rhythm Management Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Cardiac Rhythm Management Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.